Press Releases

TEL AVIV, Israel, Jan. 30, 2020 /PRNewswire/ -- The Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center, one of the

SOUTH EASTON, Mass., Jan. 30, 2020 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced that the Company plans to release a benchtop, R&

FLORENCE, Italy, Jan. 30, 2020 /PRNewswire/ -- The introduction of new antibiotics would reduce the number of deaths related to superbugs from 50-55% to 10-15%: if these new antibiotics were used, one third of lives would be saved with more than 230,000 deaths averted at a global level per year, 11,000 of which only in Europe.

MINNEAPOLIS, Jan. 30, 2020 /PRNewswire/ -- VentureMed Group, Inc., a privately-held medical device innovator focused on vessel preparation for interventional treatment of peripheral arterial disease (PAD) and stenoses of arteriovenous (AV) fistulas and grafts, announced data presented at the International Symposium on Intervascular Therapy (ISET) Annual Conference

EDISON, N.J., Jan. 30, 2020 /PRNewswire/ -- Lily Bioceuticals™ CEO Michael Kruel reports, "We've provided women over 40 with a much younger-looking face on which to apply make-up and it lasts an entire day and night.  The enthusiastic response we are receiving from women and men is heartwarming."

TORONTO, Jan. 30, 2020 /PRNewswire/ - Portage Biotech Inc. (PBT.U, OTC Markets: PTGEF) ("Portage" or the "Company") is pleased to announce that it has increased its subscription to iOx's convertible loan to $2.9M USD, (previous subscriptions totalled $1.9M on December 8th, 2018).

PORTLAND, Ore., Jan. 30, 2020 /PRNewswire/ -- In response to the

DAVIS, Calif., Jan. 30, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of c

FOSTER CITY, Calif., Jan. 30, 2020 /PRNewswire/ -- SutroVax, a biopharmaceutical company dedicated to developing best-in-class conjugate vaccines and novel complex antigen-based vaccines designed to prevent serious infectious diseases, today announced the appointment of Jim Wassil, MS, MBA as Chief Operating Officer. In this role,

SALT LAKE CITY, Jan. 30, 2020 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT) today announced a strategic partnership with